Gero is a data-driven biotech company. We develop new drugs against aging and other complex diseases using our AI platform. Founders: @fedichev and @geromaxim
Thanks @Nasdaq for celebrating our recent partnership with @chugai_cc to develop novel therapies for age-related diseases. 🧬🧬
Read the news: shorturl.at/JZAck
Curious to learn more about Gero? ⬇️
Our mission is to eliminate the root causes of age-related diseases by designing drugs that treat aging as a system-level failure, not a fixed destiny.
💻 Discover how we’re making it happen: gero.ai
Menopause affects nearly every woman, yet there are zero drugs in development beyond symptom management. 📉
OVARIA, the joint effort between Gero and @athenabiorg, combats this by running genome-wide and rare-variant association studies to identify new therapeutic targets.
We aim to identify mechanisms that influence the rate of aging.
Our mission at Gero is to develop drugs that restore resilience, delay disease, and double healthy human lifespan within a single generation.
Aging is complex. 📊
At Gero, our work to extend functional lifespan is enabled by a physics-first approach.
📽️Our Co-founder and CEO, @fedichev, shared more about how our models work with @MHealthspan: youtu.be/NU8RAZhQhT4?si…